References
Granger CB, et al. Drugs 44: 293–325, 1992
GISSI. Lancet 336: 65–71, 1990
ISIS-3 Collaborative Group. Lancet 339: 753–770, 1992
Lew AS, et al. Circulation 72: 1321–1326, 1985
Yusuf S, et al. Circulation 82 (Suppl. II): II–117–II–134, 1990
Pindur G, et al. Thrombosis Research 67: 191–200, 1992
Topol EJ. J Am Coll Cardiol 145: 922–924, 1990
Bovill EG, et al. Ann Intern Med 115: 256–265, 1991
Smalling RW, et al. J Am Coll Cardiol 15: 915–921, 1990
Califf RM, et al. Am J Cardiol 69: 12A–20A, 1992
DeWood MA, et al. N Engl J Med 303: 897–902, 1980
Rentrop KP, et al. Clin Cardiol 2: 92–105, 1979
Dalen JE, et al. Am J Cardiol 62: 179–185, 1985
Sharma GVRK, et al. N Engl J Med 306: 1268–1276, 1982
ISIS-2 Collaborative Group. Lancet 2: 349–360, 1988
GISSI. Lancet 1: 397–402, 1986
GISSI. Lancet 1: 871–874, 1987
AIMS Trial Study Group. Lancet 335: 427–431, 1990
Anderson JL, et al. Circulation 83: 126–140, 1991
Ohman EM, et al. Circulation 82: 781–791, 1990
Verstraete M. Circulation 82 (Suppl. II): II–96–II–109, 1990
Williamson BD, et al. Drugs & Aging 2: 461–468, 1992
Woo KS, White HD. Drug Safety 8: 19–29, 1993
Gore JM, et al. Circulation 83: 448–459, 1991
Maggioni AP, et al. BMJ 302: 1428–1431, 1991
Maggioni AP, et al. N Engl J Med 327: 1–6, 1992
Elliott JM, et al. Circulation 84 (Suppl. II): II–116, 1991
Rights and permissions
About this article
Cite this article
Thrombolytics Improve Survival After Acute MI. Drugs Ther. Perspect 1, 7–11 (1993). https://doi.org/10.2165/00042310-199301050-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199301050-00003